Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

ema.europa.eu

What's new

Get the latest updates from What's new directly as they happen.

Follow now 448 followers

Latest posts

Last updated about 6 hours ago

IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants

about 11 hours ago

IRIS guide for applicants - How to create, submit and manage IRIS...

Portfolio and technology meetings

about 6 hours ago

Portfolio and technology meetings

Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation: 23/08/2018, Revision: 24, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Kymriah, tisagenlecleucel, Date of authorisation...

Human medicines European public assessment report (EPAR): Myqorzo, aficamten, Date of authorisation: 12/02/2026, Revision: 2, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Myqorzo, aficamten, Date of authorisation...

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation: 26/05/2023, Revision: 9, Status: Authorised

about 6 hours ago

Human medicines European public assessment report (EPAR): Omvoh, mirikizumab, Date of authorisation...

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date of authorisation: 26/03/2021, Revision: 4, Status: Authorised

about 7 hours ago

Human medicines European public assessment report (EPAR): Seffalair Spiromax, salmeterol,fluticasone propionate, Date...

COVID-19 medicines

about 8 hours ago

COVID-19 medicines

Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation: 26/06/2025, Revision: 2, Status: Authorised

about 10 hours ago

Human medicines European public assessment report (EPAR): Zadenvi, denosumab, Date of authorisation...

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, 22 October 2026

about 9 hours ago

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the...

Voluntary data submission (VDS) pilot application form

about 9 hours ago

Voluntary data submission (VDS) pilot application form